227 related articles for article (PubMed ID: 29074982)
21. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
[TBL] [Abstract][Full Text] [Related]
22. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
[TBL] [Abstract][Full Text] [Related]
23. High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS.
Thebault S; R Tessier D; Lee H; Bowman M; Bar-Or A; Arnold DL; L Atkins H; Tabard-Cossa V; Freedman MS
Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e598. PubMed ID: 31516913
[TBL] [Abstract][Full Text] [Related]
24. Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients.
Szejko N; Picón C; García-Caldentey J; de Yebenes JG; Alvarez-Cermeño JC; Villar LM; López-Sendón Moreno JL
PLoS Curr; 2018 Aug; 10():. PubMed ID: 30258698
[TBL] [Abstract][Full Text] [Related]
25. Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease.
Sánchez-Valle R; Heslegrave A; Foiani MS; Bosch B; Antonell A; Balasa M; Lladó A; Zetterberg H; Fox NC
Alzheimers Res Ther; 2018 Nov; 10(1):113. PubMed ID: 30390718
[TBL] [Abstract][Full Text] [Related]
26. Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke.
Pujol-Calderón F; Portelius E; Zetterberg H; Blennow K; Rosengren LE; Höglund K
Neurosci Lett; 2019 Apr; 698():58-63. PubMed ID: 30599262
[TBL] [Abstract][Full Text] [Related]
27. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen.
Wurster CD; Steinacker P; Günther R; Koch JC; Lingor P; Uzelac Z; Witzel S; Wollinsky K; Winter B; Osmanovic A; Schreiber-Katz O; Al Shweiki R; Ludolph AC; Petri S; Hermann A; Otto M;
J Neurol; 2020 Jan; 267(1):36-44. PubMed ID: 31552549
[TBL] [Abstract][Full Text] [Related]
28. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
[TBL] [Abstract][Full Text] [Related]
29. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
[TBL] [Abstract][Full Text] [Related]
30. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
Wilke C; Pujol-Calderón F; Barro C; Stransky E; Blennow K; Michalak Z; Deuschle C; Jeromin A; Zetterberg H; Schüle R; Höglund K; Kuhle J; Synofzik M
Clin Chem Lab Med; 2019 Sep; 57(10):1556-1564. PubMed ID: 31251725
[TBL] [Abstract][Full Text] [Related]
31. Serum Neurofilament Light in Patients with Frontotemporal Dementia Caused by CHMP2B Mutation.
Toft A; Roos P; Jääskeläinen O; Musaeus CS; Henriksen EE; Johannsen P; Nielsen TT; Herukka SK; Hviid Simonsen A; Nielsen JE
Dement Geriatr Cogn Disord; 2020; 49(6):533-538. PubMed ID: 33626531
[TBL] [Abstract][Full Text] [Related]
32. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.
Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price RW; Rosengren L; Gisslén M
J Neurol; 2007 Aug; 254(8):1026-32. PubMed ID: 17420923
[TBL] [Abstract][Full Text] [Related]
33. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
[TBL] [Abstract][Full Text] [Related]
34. Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
Rodrigues FB; Byrne LM; Tortelli R; Johnson EB; Wijeratne PA; Arridge M; De Vita E; Ghazaleh N; Houghton R; Furby H; Alexander DC; Tabrizi SJ; Schobel S; Scahill RI; Heslegrave A; Zetterberg H; Wild EJ
Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328328
[TBL] [Abstract][Full Text] [Related]
35. CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.
Rojas JC; Bang J; Lobach IV; Tsai RM; Rabinovici GD; Miller BL; Boxer AL;
Neurology; 2018 Jan; 90(4):e273-e281. PubMed ID: 29282336
[TBL] [Abstract][Full Text] [Related]
36. Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Kuhle J; Barro C; Disanto G; Mathias A; Soneson C; Bonnier G; Yaldizli Ö; Regeniter A; Derfuss T; Canales M; Schluep M; Du Pasquier R; Krueger G; Granziera C
Mult Scler; 2016 Oct; 22(12):1550-1559. PubMed ID: 26754800
[TBL] [Abstract][Full Text] [Related]
37. Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
Ashton NJ; Leuzy A; Lim YM; Troakes C; Hortobágyi T; Höglund K; Aarsland D; Lovestone S; Schöll M; Blennow K; Zetterberg H; Hye A
Acta Neuropathol Commun; 2019 Jan; 7(1):5. PubMed ID: 30626432
[TBL] [Abstract][Full Text] [Related]
38. Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
Meregalli C; Fumagalli G; Alberti P; Canta A; Chiorazzi A; Monza L; Pozzi E; Carozzi VA; Blennow K; Zetterberg H; Cavaletti G; Marmiroli P
Arch Toxicol; 2020 Jul; 94(7):2517-2522. PubMed ID: 32333051
[TBL] [Abstract][Full Text] [Related]
39. Ratio and index of Neurofilament light chain indicate its origin in Guillain-Barré Syndrome.
Körtvelyessy P; Kuhle J; Düzel E; Vielhaber S; Schmidt C; Heinius A; Leypoldt F; Schraven B; Reinhold D; Leppert D; Goihl A
Ann Clin Transl Neurol; 2020 Nov; 7(11):2213-2220. PubMed ID: 33030817
[TBL] [Abstract][Full Text] [Related]
40. Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
Weston PSJ; Poole T; Ryan NS; Nair A; Liang Y; Macpherson K; Druyeh R; Malone IB; Ahsan RL; Pemberton H; Klimova J; Mead S; Blennow K; Rossor MN; Schott JM; Zetterberg H; Fox NC
Neurology; 2017 Nov; 89(21):2167-2175. PubMed ID: 29070659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
